NCT02817997View on ClinicalTrials.gov

International Registry for Patients With Castleman Disease

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Castleman DiseaseCastleman's DiseaseGiant Lymph Node HyperplasiaAngiofollicular Lymph HyperplasiaAngiofollicular Lymph Node HyperplasiaAngiofollicular Lymphoid HyperplasiaGLNHHyperplasia, Giant Lymph NodeLymph Node Hyperplasia, Giant
Trial Locations (1)

19104

RECRUITING

University of Pennsylvania, Philadelphia

Sponsors

Collaborators (1)

EUSA Pharma, Inc.
All Listed Sponsors
collaborator

EUSA Pharma, Inc.

INDUSTRY

collaborator

Castleman Disease Collaborative Network

OTHER

collaborator

Food and Drug Administration (FDA)

FED

lead

University of Pennsylvania

OTHER

NCT02817997 - International Registry for Patients With Castleman Disease | Biotech Hunter | Biotech Hunter